Within this systematic review and meta-analysis encompassing 7 studies involving 778 early-stage mycosis fungoides patients, the response rates to narrowband UV-B were akin to those observed with psoralen–UV-A. Notably, no significant divergence was identified between narrowband UV-B and psoralen–UV-A concerning adverse effects.
Citation: Phan K, Ramachandran V, Fassihi H, Sebaratnam DF. Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019 Mar 1;155(3):335-341. doi: 10.1001/jamadermatol.2018.5204. PMID: 30698622; PMCID: PMC6439931.
